Erica Kubly Associate

Erica is a litigation associate at Seeger Weiss. Her practice focuses primarily on mass tort litigation involving pharmaceutical injury.

Erica is a litigation associate at Seeger Weiss. Her practice focuses primarily on mass tort litigation involving pharmaceutical injury.

  • Member of the Seeger Weiss trial team appointed Lead Trial Counsel in representing Tennessee plaintiff as part of a multidistrict litigation against pharmaceutical giant AbbVie, for fraudulently marketing testosterone drug AndroGel; the plaintiff was awarded $140 million in punitive damages by a federal jury in Chicago. Involvement included preparing regulatory expert for testimony as well as assisting in the preparation for cross examination of a corporate witness.

 

  • Member of the trial team appointed Co-Lead Counsel in representing Oregon plaintiff as part of the MDL against AbbVie; the plaintiff was awarded $150 million in punitive damages by a federal jury in Chicago. Involvement included preparing regulatory expert for testimony as well as assisting in the preparation for cross-examination of a corporate witness.

 

  • Member of trial team appointed to the Plaintiffs’ Executive Committee in an MDL against Fresenius Medical Care Holdings, alleging defective design and failure to warn concerning its dry acid concentrate products, Granuflo and Naturalyte, which were subject to a Class I recall by the FDA. Involvement included discovery and assisting in preparation of corporate witnesses. Helped secure a $250 million settlement agreement.

 

  • Member of the trial team representing plaintiffs in MDL against Depuy Orthopedics, a subsidiary of Johnson & Johnson, on claims concerning defective design, failure to warn and unfair and deceptive trade practices concerning their ASR hip implant product. Involvement included discovery and assisting in preparation of corporate witness depositions.

 

  • Member of the trial team appointed Co-Lead Counsel in the AbbVie MDL, representing plaintiffs against the makers of testosterone replacement therapy products, alleging injuries including myocardial infarction, stroke, pulmonary embolism and deep vein thrombosis. Involvement includes discovery responsibilities and brief writing. Case pending.

Bar Admissions

New York

Education

J.D., Benjamin N. Cardozo School of Law, 2008 (Moot Court Honor Society)
B.A., University of California – Los Angeles (UCLA), 2003

ekubly@seegerweiss.com

New York

P: 212-584-0700
F: 212-584-0799

77 Water Street
8th Floor
New York, NY 10005